Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

U. of Wash. issues a literature situation report 5

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154678
(Total Views: 971)
Posted On: 10/12/2020 1:12:06 PM
Posted By: Enjay
U. of Wash. issues a literature situation report 5 days/week

I saw an article today about a "COVID-19 Literature Situation Report" that a small team of faculty and students at U. of Washington puts out 5 days/week (M-F). You can see this article at the following link:

https://www.seattletimes.com/seattle-news/hea...t-have-to/

Here are some excerpts to give a brief outline of what they do.

A typical report includes a list of key takeaways and summaries of a dozen or so studies, sorted into categories like “testing and treatment,” “transmission” and “public health policy.” There’s also a shortlist of other interesting research, along with links for those who want to delve more deeply.

The students gather the raw materials, using standard search terms to pull all the new studies posted on PubMed, a free government search engine, and medRxiv and bioRxiv, which posts preprints before peer review. They also manually check several high-profile journals, including the Lancet and the New England Journal of Medicine.

The average haul is about 400 papers a day but can range between 200 and 1,000. What the team is looking for are well-designed and executed studies with public health significance. Vaccine updates, analyses of school openings, modeling projections and reports about the impact of masks or social distancing get high priority.

I thought some of our posters who are keeping up with recent developments might be interested in receiving this report. The link below will take you to their website where you can see recent reports as well as subscribe to receive their daily email reports.

https://depts.washington.edu/pandemicalliance...on-report/




(4)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us